Bone marrow transplantation in two multiply transfused patients with thalassaemia major. 1986

J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly

Bone marrow transplantation has generally been unsuccessful when applied to patients with thalassaemia major over the age of 6 years. We report here two successful transplants for this disorder in a 7 1/2-year-old boy and an 11-year-old girl following a pre-transplant cytoreductive/immunosuppressive regimen of total body irradiation and cyclophosphamide. Complete durable engraftment of donor haematopoietic and lymphoid populations was documented through several approaches, including cytogenetic analysis, haemoglobin electrophoresis, globin chain synthetic ratios, red cell typing and DNA restriction enzyme analysis. Both patients are surviving in good health, 28 and 9 months from transplantation. The successful outcome in these patients demonstrates the feasibility of marrow transplantation for the treatment of thalassaemia in multiply transfused and, presumably, highly sensitized patients.

UI MeSH Term Description Entries
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
August 1990, Journal of clinical pathology,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
January 1993, Bone marrow transplantation,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
July 1992, Journal of clinical pathology,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
July 1985, Lancet (London, England),
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
April 1994, Bone marrow transplantation,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
January 2003, British journal of haematology,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
May 1986, Bone marrow transplantation,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
January 1993, Bone marrow transplantation,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
March 1986, The Medical journal of Australia,
J A Brochstein, and D Kirkpatrick, and P J Giardina, and R S Weinberg, and B P Alter, and C Driscoll, and L Wolfe, and B Shank, and R J O'Reilly
January 1997, Journal of internal medicine. Supplement,
Copied contents to your clipboard!